{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:52:37Z","timestamp":1792727557467,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecules and Cells"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.14348\/molcells.2015.2302","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T03:50:53Z","timestamp":1422589853000},"page":"251-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Brca2 Deficiency Leads to T Cell Loss and Immune Dysfunction"],"prefix":"10.1016","volume":"38","author":[{"given":"Jun-hyeon","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areum","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilgu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Ock","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14348\/molcells.2015.2302_bib1","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood-2002-11-3597","article-title":"Cancer in Fanconi anemia.","volume":"101","author":"Alter","year":"2003","journal-title":"Blood"},{"key":"10.14348\/molcells.2015.2302_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/1098-2744(200007)28:3<174::AID-MC6>3.0.CO;2-C","article-title":"BRCA2-null embryonic survival is prolonged on the BALB\/c genetic background.","volume":"28","author":"Bennett","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.14348\/molcells.2015.2302_bib3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00335-002-2300-2","article-title":"Genomic organization and expression of the mouse Brca2 gene.","volume":"13","author":"Callens","year":"2002","journal-title":"Mamm. Genome"},{"key":"10.14348\/molcells.2015.2302_bib4","first-page":"6194","article-title":"Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.","volume":"62","author":"Cheung","year":"2002","journal-title":"Cancer Res."},{"key":"10.14348\/molcells.2015.2302_bib5","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1158\/0008-5472.CAN-03-2270","article-title":"Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+\/\u2212) mutant mice.","volume":"64","author":"Cheung","year":"2004","journal-title":"Cancer Res."},{"key":"10.14348\/molcells.2015.2302_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.devcel.2012.01.009","article-title":"BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation.","volume":"22","author":"Choi","year":"2012","journal-title":"Dev. Cell"},{"key":"10.14348\/molcells.2015.2302_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ng1297-423","article-title":"Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.","volume":"17","author":"Connor","year":"1997","journal-title":"Nat. Genet."},{"key":"10.14348\/molcells.2015.2302_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","article-title":"BRCA2 germline mutations in male breast cancer cases and breast cancer families.","volume":"13","author":"Couch","year":"1996","journal-title":"Nat. Genet."},{"key":"10.14348\/molcells.2015.2302_bib9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.molmed.2010.09.002","article-title":"p53 post-translational modification: deregulated in tumorigenesis.","volume":"16","author":"Dai","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.14348\/molcells.2015.2302_bib10","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.4049\/jimmunol.179.10.6547","article-title":"Naive and memory T cells induce different types of graft-versus-host disease.","volume":"179","author":"Dutt","year":"2007","journal-title":"J. Immunol."},{"key":"10.14348\/molcells.2015.2302_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.immunol.16.1.201","article-title":"T cell memory.","volume":"16","author":"Dutton","year":"1998","journal-title":"Ann. Rev. Immunol."},{"key":"10.14348\/molcells.2015.2302_bib12","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/sj.onc.1209871","article-title":"Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects.","volume":"25","author":"Evers","year":"2006","journal-title":"Oncogene"},{"key":"10.14348\/molcells.2015.2302_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mc.10081","article-title":"Thymic model for examining BRCA2 expression and function.","volume":"35","author":"Flores","year":"2002","journal-title":"Mol. Carcinog."},{"key":"10.14348\/molcells.2015.2302_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.14348\/molcells.2015.2302_bib15","first-page":"1338","article-title":"Thymic lymphomas in mice with a truncating mutation in Brca2.","volume":"58","author":"Friedman","year":"1998","journal-title":"Cancer Res."},{"key":"10.14348\/molcells.2015.2302_bib16","first-page":"5360","article-title":"Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.","volume":"56","author":"Goggins","year":"1996","journal-title":"Cancer Res."},{"key":"10.14348\/molcells.2015.2302_bib17","first-page":"859","article-title":"BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.","volume":"58","author":"Gretarsdottir","year":"1998","journal-title":"Cancer Res."},{"key":"10.14348\/molcells.2015.2302_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.8016642","article-title":"Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting.","volume":"265","author":"Gu","year":"1994","journal-title":"Science"},{"key":"10.14348\/molcells.2015.2302_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nsmb.2096","article-title":"Unraveling the mechanism of BRCA2 in homologous recombination.","volume":"18","author":"Holloman","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.14348\/molcells.2015.2302_bib20","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia.","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"10.14348\/molcells.2015.2302_bib21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat. Genet."},{"key":"10.14348\/molcells.2015.2302_bib22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cellsig.2010.01.013","article-title":"Examination of the expanding pathways for the regulation of p21 expression and activity.","volume":"22","author":"Jung","year":"2010","journal-title":"Cell. Signal."},{"key":"10.14348\/molcells.2015.2302_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.14348\/molcells.2015.2302_bib24","first-page":"491","article-title":"Fanconi anemia: a signal transduction and DNA repair pathway.","volume":"86","author":"Kupfer","year":"2013","journal-title":"Yale J. Biol. Med."},{"key":"10.14348\/molcells.2015.2302_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1097-2765(00)80182-3","article-title":"Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.","volume":"4","author":"Lee","year":"1999","journal-title":"Mol. Cell"},{"key":"10.14348\/molcells.2015.2302_bib26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1101\/gad.11.10.1226","article-title":"Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1\/Brca2, Brca1\/p53, and Brca2\/p53 nullizygous embryos.","volume":"11","author":"Ludwig","year":"1997","journal-title":"Genes Dev."},{"key":"10.14348\/molcells.2015.2302_bib27","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1038\/sj.onc.1204512","article-title":"Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice.","volume":"20","author":"Ludwig","year":"2001","journal-title":"Oncogene"},{"key":"10.14348\/molcells.2015.2302_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.276.5312.531","article-title":"Possible function found for breast cancer genes.","volume":"276","author":"Marx","year":"1997","journal-title":"Science"},{"key":"10.14348\/molcells.2015.2302_bib29","first-page":"990","article-title":"Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene.","volume":"62","author":"McAllister","year":"2002","journal-title":"Cancer Res."},{"key":"10.14348\/molcells.2015.2302_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10689-011-9506-2","article-title":"Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.","volume":"11","author":"Moran","year":"2012","journal-title":"Fam. Cancer"},{"key":"10.14348\/molcells.2015.2302_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng0596-126","article-title":"Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.","volume":"13","author":"Neuhausen","year":"1996","journal-title":"Nat. Genet."},{"key":"10.14348\/molcells.2015.2302_bib32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3858\/emm.2008.40.3.339","article-title":"Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.","volume":"40","author":"Park","year":"2008","journal-title":"Exp. Mol. Med."},{"key":"10.14348\/molcells.2015.2302_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1097-2765(00)80035-0","article-title":"Involvement of Brca2 in DNA repair.","volume":"1","author":"Patel","year":"1998","journal-title":"Mol. Cell"},{"key":"10.14348\/molcells.2015.2302_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature01230","article-title":"Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.","volume":"420","author":"Pellegrini","year":"2002","journal-title":"Nature"},{"key":"10.14348\/molcells.2015.2302_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/dbio.1997.8526","article-title":"Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.","volume":"184","author":"Rajan","year":"1997","journal-title":"Dev. Biol."},{"key":"10.14348\/molcells.2015.2302_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5","article-title":"Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.","volume":"25","author":"Ramus","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.14348\/molcells.2015.2302_bib37","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","article-title":"Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.","volume":"98","author":"Risch","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.14348\/molcells.2015.2302_bib38","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/386804a0","article-title":"Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.","volume":"386","author":"Sharan","year":"1997","journal-title":"Nature"},{"key":"10.14348\/molcells.2015.2302_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.14348\/molcells.2015.2302_bib40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/MCB.24.3.976-984.2004","article-title":"Phosphorylation of serine 18 regulates distinct p53 functions in mice.","volume":"24","author":"Sluss","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.14348\/molcells.2015.2302_bib41","doi-asserted-by":"crossref","first-page":"13920","DOI":"10.1073\/pnas.96.24.13920","article-title":"Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.","volume":"96","author":"Spain","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.14348\/molcells.2015.2302_bib42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1101\/gad.11.10.1242","article-title":"Brca2 is required for embryonic cellular proliferation in the mouse.","volume":"11","author":"Suzuki","year":"1997","journal-title":"Genes Dev."},{"key":"10.14348\/molcells.2015.2302_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat. Genet."},{"key":"10.14348\/molcells.2015.2302_bib44","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1038\/sj.onc.1210870","article-title":"BRCA2: a universal recombinase regulator.","volume":"26","author":"Thorslund","year":"2007","journal-title":"Oncogene"},{"key":"10.14348\/molcells.2015.2302_bib45","doi-asserted-by":"crossref","first-page":"31941","DOI":"10.1074\/jbc.272.51.31941","article-title":"RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2.","volume":"272","author":"Wong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.14348\/molcells.2015.2302_bib46","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/sj.onc.1207314","article-title":"A delayed chemically induced tumorigenesis in Brca2 mutant mice.","volume":"23","author":"Yan","year":"2004","journal-title":"Oncogene"},{"key":"10.14348\/molcells.2015.2302_bib47","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.2627984100","article-title":"PUMA mediates the apoptotic response to p53 in colorectal cancer cells.","volume":"100","author":"Yu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecules and Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016847823054237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016847823054237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ocean.kisti.re.kr\/downfile\/crosscheck\/ksmcb\/JAKO201510534325479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:51:04Z","timestamp":1760896264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1016847823054237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1016847823054237"],"URL":"https:\/\/doi.org\/10.14348\/molcells.2015.2302","relation":{},"ISSN":["1016-8478"],"issn-type":[{"value":"1016-8478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brca2 Deficiency Leads to T Cell Loss and Immune Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Molecules and Cells","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14348\/molcells.2015.2302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 THE AUTHORS. Published by Elsevier Inc on behalf of the Korean Society for Molecular and Cellular Biology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}